General Information of the Compound
Compound ID
CP0244395
Compound Name
3-(quinolin-6-ylmethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine
    Show/Hide
Structure
Formula
C15H12N6
Molecular Weight
276.303
Canonical SMILES
Nc1ccc2nnc(Cc3ccc4ncccc4c3)n2n1
    Show/Hide
InChI
InChI=1S/C15H12N6/c16-13-5-6-14-18-19-15(21(14)20-13)9-10-3-4-12-11(8-10)2-1-7-17-12/h1-8H,9H2,(H2,16,20)
    Show/Hide
InChIKey
XTBRTNOQECRDLG-UHFFFAOYSA-N
Physicochemical Property
logP
1.8455
Rotatable Bonds
2
Heavy Atom Count
21
Polar Areas
81.99
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71148153
ChEMBL ID
CHEMBL2431820
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01201, Hepatocyte growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000068 A-549 Homo sapiens (Human)  1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 379 nM